ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,497, issued on Feb. 17, was assigned to EMORY UNIVERSITY (Atlanta).

"N4-hydroxycytidine and derivatives and anti-viral uses related thereto" was invented by George R. Painter (Atlanta), David Guthrie (Bel Air, Md.), Gregory R. Bluemling (Decatur, Ga.) and Michael G. Natchus (Alpharetta, Ga.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure related to N4-hydroxycytidine derivatives, compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment and prophylaxis of viral infections."

The patent was filed on March 15, 2023, under Application No. 18/184,288.

*For further information, including im...